Summary
Signal counts
Assets tracked: 2
Watchlist assets: 0
Registry stop assets: 0
Sponsor overview
Second Affiliated Hospital, School of Medicine, Zhejiang University
Public clinical-program risk signals across linked oncology Phase 2 assets for this sponsor.
Evidence links
Public sources
https://clinicaltrials.gov/study/NCT07617818 | https://clinicaltrials.gov/study/NCT07077564
Assets
Linked programs
- QL1706 + Cisplatin/Paclitaxel Neoadjuvant Therapy: Low Signal (0/5)
- Sac-TMT: Low Signal (0/5)